S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study

We investigated the efficacy of S-Adenosyl-L-Methionine (SAMe) augmentation in patients with treatment-resistant depressive disorder (TRD). Thirty-three outpatients with major depressive episode who failed to respond to at least 8 weeks of treatment with two adequate and stable doses of antidepressa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: De Berardis, Domenico, Marini, Stefano, Serroni, Nicola, Rapini, Gabriella, Iasevoli, Felice, Valchera, Alessandro, Signorelli, Maria, Aguglia, Eugenio, Perna, Giampaolo, Salone, Anatolia, Di Iorio, Giuseppe, Martinotti, Giovanni, Di Giannantonio, Massimo
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3666233/
https://ncbi.nlm.nih.gov/pubmed/23766680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/204649
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items